CSIMarket
 


Baxter International Inc   (NYSE: BAX)
Other Ticker:  
 

Baxter International Inc Profitability Comparisons

Select each Category to receive further Information



 

BAX Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 32.8 % 50.5 % 68.82 % 47.1 %
Gross Margin (Q1 TTM) 35.76 % 50.05 % 68.35 % 46.92 %
Gross Profit Margin 5 Yr. Avg. 37.2 % 52.59 % 66.09 % 45.81 %
EBITDA Margin (Q1 MRQ) 11.73 % 14.6 % 23.47 % 18.75 %
EBITDA Margin (Q1 TTM) 8.56 % 13.54 % 19.37 % 18.48 %
EBITDA Margin 5 Yr. Avg. 11.26 % 15.49 % 18.2 % 18.69 %
Operating Margin (Q1 MRQ) 2.21 % 9.86 % 18.49 % 15.6 %
Operating Margin (Q1 TTM) -1.19 % 7.93 % 15.54 % 15.45 %
Operating Margin 5 Yr. Avg. 3.43 % 9.41 % 13.95 % 14.31 %
Pre-Tax Profit Margin (Q1 MRQ) -0.11 % 8.02 % 15 % 11.86 %
Pre-Tax Profit Margin (Q1 TTM) -4.22 % 6.85 % 10.51 % 11.85 %
Pre-Tax Profit Margin 5 Yr. Avg. 0.73 % 8.07 % 9.32 % 10.85 %
Net Margin (Q1 MRQ) 4.8 % 5.63 % 11.63 % 9.48 %
Net Margin (Q1 TTM) -5.7 % 6.59 % 8.5 % 9.48 %
Net Margin 5 Yr. Avg. 3.12 % 7.44 % 8.13 % 8.86 %



Business Segment Profit Margin
 
2021
  Explore 2021 Segment  -
2022
  Explore 2022 Segment  -
2023
  Explore 2023 Segment  -
2024
  Explore 2024 Segment  -
2025
  Explore 2025 Segment  -
United States
  Explore United States Segment  -
International
  Explore International Segment  -
Medical Products Therapies
  Explore Medical Products Therapies Segment  -
Healthcare Systems Technologies
  Explore Healthcare Systems Technologies Segment  -
Pharmaceuticals
  Explore Pharmaceuticals Segment  10.84 %
United States Medical Products Therapies
  Explore United States Medical Products Therapies Segment  -
United States Healthcare Systems Technologies
  Explore United States Healthcare Systems Technologies Segment  -
United States Pharmaceuticals
  Explore United States Pharmaceuticals Segment  -
International Medical Products Therapies
  Explore International Medical Products Therapies Segment  -
International Healthcare Systems Technologies
  Explore International Healthcare Systems Technologies Segment  -
International Pharmaceuticals
  Explore International Pharmaceuticals Segment  -
Infusion Therapies and Technologies Medical Products Therapies
  Explore Infusion Therapies and Technologies Medical Products Therapies Segment  -
Infusion Therapies and Technologies United States Medical Products Therapies
  Explore Infusion Therapies and Technologies United States Medical Products Therapies Segment  -
Infusion Therapies and Technologies International Medical Products Therapies
  Explore Infusion Therapies and Technologies International Medical Products Therapies Segment  -
Advanced Surgery Medical Products Therapies
  Explore Advanced Surgery Medical Products Therapies Segment  -
Advanced Surgery United States Medical Products Therapies
  Explore Advanced Surgery United States Medical Products Therapies Segment  -
Advanced Surgery International Medical Products Therapies
  Explore Advanced Surgery International Medical Products Therapies Segment  -
Care and Connectivity Solutions Healthcare Systems Technologies
  Explore Care and Connectivity Solutions Healthcare Systems Technologies Segment  -
Care and Connectivity Solutions United States Healthcare Systems Technologies
  Explore Care and Connectivity Solutions United States Healthcare Systems Technologies Segment  -
Care and Connectivity Solutions International Healthcare Systems Technologies
  Explore Care and Connectivity Solutions International Healthcare Systems Technologies Segment  -
Front Line Care Healthcare Systems Technologies
  Explore Front Line Care Healthcare Systems Technologies Segment  -
Front Line Care United States Healthcare Systems Technologies
  Explore Front Line Care United States Healthcare Systems Technologies Segment  -
Front Line Care International Healthcare Systems Technologies
  Explore Front Line Care International Healthcare Systems Technologies Segment  -
Injectables and Anesthesia Pharmaceuticals
  Explore Injectables and Anesthesia Pharmaceuticals Segment  -
Injectables and Anesthesia United States Pharmaceuticals
  Explore Injectables and Anesthesia United States Pharmaceuticals Segment  -
Injectables and Anesthesia International Pharmaceuticals
  Explore Injectables and Anesthesia International Pharmaceuticals Segment  -
Drug Compounding Pharmaceuticals
  Explore Drug Compounding Pharmaceuticals Segment  -
Drug Compounding International Pharmaceuticals
  Explore Drug Compounding International Pharmaceuticals Segment  -
Other
  Explore Other Segment  -
Other United States
  Explore Other United States Segment  -
Other International
  Explore Other International Segment  -
Emerging Markets
  Explore Emerging Markets Segment  -
Rest of world
  Explore Rest of world Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) -7.35 % 0.43 % 0.34 % 0.99 %
Free Cash Flow Margin (Q1 TTM) 6.86 % 15.78 % 21.57 % 19.68 %
Free Cash Flow Margin 5 Yr. Avg. - 10.09 % 14.62 % 10.03 %
Net Cash Flow Margin (Q1 MRQ) -4.5 % -0.02 % 0.04 % -0.17 %
Net Cash Flow Margin (Q1 TTM) -7.59 % -1.36 % 0.14 % -0.59 %
Net Cash Flow Margin 5 Yr. Avg. - 1.05 % 1.73 % 6.07 %
Effective Tax Rate (Q1 MRQ) - 25.32 % 21.93 % 19.67 %
Effective Tax Rate (Q1 TTM) 26.23 % 27.78 % 21.7 % 19.92 %
Effective Tax Rate 5 Yr. Avg. - 14.44 % 19.53 % 18.81 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com